G1 Therapeutics (GTHX) Reports Q2 Loss, Tops Revenue Estimates
GTHXG1 Therapeutics(GTHX) ZACKS·2024-08-08 20:40

G1 Therapeutics (GTHX) came out with a quarterly loss of 0.10pershareversustheZacksConsensusEstimateofalossof0.10 per share versus the Zacks Consensus Estimate of a loss of 0.17. This compares to earnings of 0.14pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof41.180.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 41.18%. A quarter ago, it was expected that this company would post a loss of 0.19 per share when it actually produced a loss of $0.20, delivering a surprise of -5.26%.Over the last four quarters, the company has surp ...